Clear cell borderline tumor without fibromatous component: Pathological and literature review and report of two cases

Hada,Taira; Miyamoto,Morikazu; Ishibashi,Hiroki; Matsuura,Hiroko; Sakamoto,Takahiro; Kakimoto,Soichiro; Iwahashi,Hideki; Suzuki,Rie; Tsuda,Hitoshi; Takano,Masashi

doi:10.3892/mco.2021.2237

Clear cell borderline tumor without fibromatous component: Pathological and literature review and report of two cases

Authors:
- Taira Hada
- Morikazu Miyamoto
- Hiroki Ishibashi
- Hiroko Matsuura
- Takahiro Sakamoto
- Soichiro Kakimoto
- Hideki Iwahashi
- Rie Suzuki
- Hitoshi Tsuda
- Masashi Takano
View Affiliations

Affiliations: Department of Obstetrics and Gynecology, National Defense Medical College Hospital, Tokorozawa, Saitama 359‑8513, Japan, Department of Pathology, National Defense Medical College Hospital, Tokorozawa, Saitama 359‑8513, Japan
Published online on: February 23, 2021 https://doi.org/10.3892/mco.2021.2237
Article Number: 75

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to examine the clinical outcome of ovarian clear cell borderline tumor (CCBT) through pathological review for cases with clear cell carcinoma (CCC) and CCBT between 1984 and 2015 who received surgery at the National Defense Medical College Hospital using 2020 World Health Organization (WHO) criteria. In addition to the definition of CCBT in 2020 WHO criteria, clear cell with atypia of the glandular epithelium without fibromatous component was added to the diagnostic criteria of CCBT. Two cases with CCBT were identified through review in the current study. There were no cases that changed from the initial CCBT diagnosis that were included in the current study. Case 1 was a 43‑year‑old woman who received total hysterectomy, bilateral salpingo‑oophorectomy and partial omentectomy. Pathologically, cysts were lined by cuboidal, hobnail and clear cells with eosinophilic cytoplasm and moderate nuclear atypia without the fibromatous component. These cells were adjacent to atypical endometriosis and non‑atypical endometriosis, and the patient was diagnosed with CCBT. She exhibited no evidence of the disease for 37 months following surgery. Case 2 was a 42‑year‑old woman who received left salpingo‑oophorectomy, partial omentectomy and pelvic lymphadenectomy. The tumor exhibited a cyst (80 mm) and nodular component. Pathologically, the tumor cells were lined by hobnail cells with mild atypia and eosinophilic cytoplasm without the fibromatous component. This patient was diagnosed with CCBT and exhibited no evidence of disease for 20 months following surgery. CCBT without fibromatous component is a rare and non‑aggressive histological subtype. Additionally, regardless of fibromatous component, CCBT was able to be diagnosed.

View Figures

View References

1	Taylor HC Jr: Malignant and semimalignant tumors of the ovary. Surg Gynecol. 48:204–230. 1929.
2	Classification and staging of malignant tumours in the female pelvis. Acta Obstet Gynecol Scand 50: 1-7, 1971.
3	Serov SS, Scully RE and Sobin LH (eds); World Health Organization: Histological Typing of Ovarian Tumors. Springer, Berlin, Heidelberg, New York, NY, Geneva, 1973.
4	Silverberg SG, Bell DA, Kurman RJ, Seidman JD, Prat J, Ronnett BM, Copeland L, Silva E, Gorstein F and Young RH: Borderline ovarian tumors: Key points and workshop summary. Hum Pathol. 35:910–917. 2004.PubMed/NCBI View Article : Google Scholar
5	Trimble CL, Kosary C and Trimble EL: Long-term survival and patterns of care in women with ovarian tumors of low malignant potential. Gynecol Oncol. 86:34–37. 2002.PubMed/NCBI View Article : Google Scholar
6	Lokuhetty D, White VA and Cree IA (eds): WHO Classification of Tumours of Female Reproductive Organs. Lyon, IARC, Lyon, 2020.
7	Seidman JD, Soslow RA, Vang R, Berman JJ, Stoler MH, Sherman ME, Oliva E, Kajdacsy-Balla A, Berman DM and Copeland LJ: Borderline ovarian tumors: Diverse contemporary viewpoints on terminology and diagnostic criteria with illustrative images. Hum Pathol. 35:918–933. 2004.PubMed/NCBI View Article : Google Scholar
8	Suzuki A, Shiozawa T, Mori A, Kimura K and Konishi I: Cystic clear cell tumor of borderline malignancy of the ovary lacking fibromatous components: Report of two cases and a possible new histological subtype. Gynecol Oncol. 101:540–544. 2006.PubMed/NCBI View Article : Google Scholar
9	Pereira A, Pérez-Medina T, Magrina JF, Magtibay PM, Rodríguez-Tapia A, Peregrin I, Mendizabal E and Ortiz-Quintana L: International Federation of Gynecology and Obstetrics staging classification for cancer of the ovary, fallopian tube, and peritoneum: Estimation of survival in patients with node-positive epithelial ovarian cancer. Int J Gynecol Cancer. 25:49–54. 2015.PubMed/NCBI View Article : Google Scholar
10	Seidman JD, Soslow RA, Vang R, Berman JJ, Stoler MH, Sherman ME, Oliva E, Kajdacsy-Balla A, Berman DM and Copeland LJ: Borderline ovarian tumors: Diverse contemporary viewpoints on terminology and diagnostic criteria with illustrative images. Hum Pathol. 35:918–933. 2004.PubMed/NCBI View Article : Google Scholar
11	Hauptmann S, Friedrich K, Redline R and Avril S: Ovarian borderline tumors in the 2014 WHO classification: Evolving concepts and diagnostic criteria. Virchows Arch. 470:125–142. 2017.PubMed/NCBI View Article : Google Scholar
12	Ohishi Y, Oda Y, Kurihara S, Kaku T, Yasunaga M, Nishimura I, Okuma E, Kobayashi H, Wake N and Tsuneyoshi M: Hobnail-like cells in serous borderline tumor do not represent concomitant incipient clear cell neoplasms. Hum Pathol. 40:1168–1175. 2009.PubMed/NCBI View Article : Google Scholar
13	Ohishi Y, Kurihara S, Aman M, Takeuchi T, Imamura H, Kaku T, Kobayashi H, Wake N and Oda Y: ‘Piling up’ clear cells in müllerian-type mucinous and mixed cell-type borderline tumor do not represent concomitant clear cell neoplasms. Hum Pathol. 43:1618–1626. 2012.PubMed/NCBI View Article : Google Scholar
14	Köbel M, Kalloger SE, Boyd N, McKinney S, Mehl E, Palmer C, Leung S, Bowen NJ, Ionescu DN, Rajput A, et al: Ovarian carcinoma subtypes are different diseases: Implications for biomarker studies. PLoS Med. 5(e232)2008.PubMed/NCBI View Article : Google Scholar
15	Kato N, Sasou S and Motoyama T: Expression of hepatocyte nuclear factor-1beta (HNF-1beta) in clear cell tumors and endometriosis of the ovary. Mod Pathol. 19:83–89. 2006.PubMed/NCBI View Article : Google Scholar
16	Kao GF and Norris HJ: Unusual cytadenofibromas: Endometrioid, mucinous, and clear cell types. Obstet Gynecol. 54:729–736. 1979.PubMed/NCBI
17	Roth LM, Langley FA, Fox H, Wheeler JE and Czernobilsky B: Ovarian clear cell adenofibromatous tumors. Benign, of low malignant potential, and associated with invasive clear cell carcinoma. Cancer. 53:1156–1163. 1984.PubMed/NCBI View Article : Google Scholar
18	Bell DA and Scully RE: Benign and borderline clear cell adenofibromas of the ovary. Cancer. 56:2922–2931. 1985.PubMed/NCBI View Article : Google Scholar
19	Katsube Y, Fujiwara H, Tanioka Y, Imajo M and Fujiwara A: Ovarian clear cell adenofibroma of borderline malignancy. A case report. Hiroshima J Med Sci. 38:87–90. 1989.PubMed/NCBI
20	Liu JL, Chu PY, Yeh KT and Huang RH: Borderline clear cell adenofibroma with extensive hemorrhagic necrosis. Hematol Oncol Stem Ther. 3:158–160. 2010.PubMed/NCBI View Article : Google Scholar
21	Momotani K, Tnaka T, Iwai E, Kanda T, Munakata S and Ohmichi M: Ovarian clear cell adenofibromatous tumor of borderline malignancy associated with high levels of carbohydrate antigen 9-9. J Obstet Gynaecol Res. 37:472–477. 2011.PubMed/NCBI View Article : Google Scholar
22	Zhao C, Wu LS and Barner R: Pathogenesis of ovarian clear cell adenofibroma, atypical proliferative (borderline) tumor, and carcinoma: Clinicopathologic features of tumors with endometriosis or adenofibromatous components support two related pathways of tumor development. J Cancer. 2:94–103. 2011.PubMed/NCBI View Article : Google Scholar
23	Cakir E, Aydin E, Durmus NI, Samdanci E, Sahin N and Nurkabul Z: Primary ovarian clear cell adenofibroma of borderline malignancy. Oman Med J. 27(e031)2012.PubMed/NCBI View Article : Google Scholar
24	Vasilakaki T, Skafida E, Arkoumani E, Grammatoglou X, Firfiris N and Manoloudaki K: Borderline clear cell adenofibroma of the ovary associated with ovarian endometriosis: A case report. Eur J Gynarcol Oncol. 33:230–232. 2012.PubMed/NCBI
25	Uzan C, Dufeu-Lefebvre M, Fauvet R, Gouy S, Duvillard P, Darai E and Morice P: Management and prognosis of clear cell borderline ovarian tumor. Int J Gynecol Cancer. 22:993–999. 2012.PubMed/NCBI View Article : Google Scholar
26	Kleebkaow P, Aue-Aungkul A, Temtanakitpaisan A and Kietpeerakool C: Borderline clear cell adenofibroma of the ovary. Case Rep Pathol. 2017(3860107)2017.PubMed/NCBI View Article : Google Scholar